JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, cilt.92, sa.5, ss.1881-1885, 2007 (SCI-Expanded)
Context: Asymmetric dimethylarginine ( ADMA) has recently emerged as an independent risk marker for cardiovascular disease, but studies investigating the ADMA levels in type 1 diabetes mellitus ( DM) are scarce.